6 papers
Analysis of the MICCAI Brain Tumor Segmentation -- Metastases (BraTS-METS) 2025 Lighthouse Challenge: Brain Metastasis Segmentation on Pre- and Post-treatment MRI
Nazanin Maleki, Raisa Amiruddin, Ahmed W. Moawad +240
Despite continuous advancements in cancer treatment, brain metastatic disease remains a significant complication of primary cancer and is associated with an unfavorable prognosis.…
BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023
Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu +77
Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%.…
The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI
Maria Correia de Verdier, Rachit Saluja, Louis Gagnon +82
Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the gene…
BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions
Spyridon Bakas, Siddhesh P. Thakur, Shahriar Faghani +19
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is wide…
Analysis of the 2024 BraTS Meningioma Radiotherapy Planning Automated Segmentation Challenge
Dominic LaBella, Valeriia Abramova, Mehdi Astaraki +102
The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT) challenge aimed to advance automated segmentation algorithms using the largest known multi-institutional da…
Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge
Dominic LaBella, Ujjwal Baid, Omaditya Khanna +119
We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in…